Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $5.3K | $5.3K | $5.3K | $5.3K |
| Gross profit | $0 | $0 | $0 | $0 | −$5.3K | −$5.3K | −$5.3K | −$5.3K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $180.0K | $0 | $0 | $0 |
| Operating income | −$609.0K | −$901.0K | −$680.0K | −$606.0K | −$3.9M | −$739.0K | −$741.0K | −$1.0M |
| EBITDA | −$529.0K | −$901.0K | −$98.9K | −$152.0K | −$3.3M | −$483.7K | −$735.0K | −$1.0M |
| Net income | −$546.0K | −$1.1M | −$779.0K | −$758.0K | −$4.0M | −$518.0K | −$774.0K | −$1.0M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.02 | -0.03 | -0.02 | -0.02 | -0.11 | -0.02 | -0.04 | -0.04 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds GTHR.
No tracked institution reports a position in GTHR as of their last filing.
No one on the platform has traded GTHR yet.
| $3496 |
| — |
| EPRSQEPIRUS Biopharmaceuticals, Inc. | $0.00 | -99.00% | $1571 | — |
| ERUCER Urgent Care Holdings, Inc. | $0.00 | +0.00% | $3915 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.